Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.

Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.

Submitted by admin on July 15, 2024 - 9:53am
Source: 
Motley Fool
News Tags: 
Eli Lilly
Kisunla
FDA
Alzheimer's disease`
Headline: 
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
snippet: 
  • The Food and Drug Administration recently approved Kisunla as a treatment for early symptomatic Alzheimer's disease.
  • Despite the news, shares of Eli Lilly didn't take off.
  • Much of the enthusiasm behind the stock centers around its promising weight loss and diabetes products.

Do Not Allow Advertisers to Use My Personal information